Publications by authors named "M A Casillas"

The lack of diversity in the language sciences has increasingly been criticized as it holds the potential for producing flawed theories. Research on (i) geographically diverse language communities and (ii) on sign languages is necessary to corroborate, sharpen, and extend existing theories. This study contributes a case study of adapting a well-established paradigm to study the acquisition of sign phonology in Kata Kolok, a sign language of rural Bali, Indonesia.

View Article and Find Full Text PDF

We present an exploratory cross-linguistic analysis of the quantity of target-child-directed speech and adult-directed speech in North American English (US & Canadian), United Kingdom English, Argentinian Spanish, Tseltal (Tenejapa, Mayan), and Yélî Dnye (Rossel Island, Papuan), using annotations from 69 children aged 2-36 months. Using a novel methodological approach, our cross-linguistic and cross-cultural findings support prior work suggesting that target-child-directed speech quantities are stable across early development, while adult-directed speech decreases. A preponderance of speech from women was found to a similar degree across groups, with less target-child-directed speech from men and children in the North American samples than elsewhere.

View Article and Find Full Text PDF
Article Synopsis
  • Atopic dermatitis is a chronic skin condition that causes symptoms like itching and sleep disturbances, impacting quality of life, and lebrikizumab, an interleukin-13 inhibitor, is approved for treating moderate-to-severe cases in various countries.
  • In two phase 3 studies (ADvocate1 and ADvocate2), adults and adolescents with moderate-to-severe atopic dermatitis received either lebrikizumab or a placebo every two weeks for 16 weeks to assess treatment efficacy.
  • Results demonstrated significant improvements in skin severity, itching, sleep loss, and quality of life metrics for patients taking lebrikizumab compared to those on placebo, particularly notable after 16 weeks of treatment.
View Article and Find Full Text PDF